EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Outcomes of adolescent bariatric surgery: liver disease

Christine Brichta, Mark Fishbein, Justin R Ryder

Surgery for Obesity and Related Diseases · 2025

DOI: 10.1016/j.soard.2024.08.040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Surgery for Obesity and Related Diseases, 2025. Verfasst von Christine Brichta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, & Nutrition, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illin…. Hauptthemen laut MEDLINE: Bariatric Surgery, Pediatric Obesity, Obesity, Morbid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing among children in the United States as pediatric obesity rates continue to rise. As such, metabolic and bariatric surgery (MBS) has become a more recognized option for treatment of obesity and has been recommended by the American Academy of Pediatrics. Although MBS is known to improve many obesity-associated comorbidities, such as hypertension and type 2 diabetes, less is known about its effect as a treatment for MASLD. This article reviewed the impact MBS has on the course of liver disease as measured by histopathology, serum markers, and radiographic imaging, among adolescents with severe obesity. Improvements were seen in alanine transaminase (ALT) liver enzymes, rates of hepatocyte steatosis, and degree of fibrosis on histopathology, and fat content in the liver on computed tomography and magnetic resonance imaging. Greater improvements in ALT were seen in patients with higher baseline values and/or a higher stage of biopsy-confirmed steatohepatitis. Biopsy-proven MASLD and metabolic dysfunction-associated steatohepatitis (MASH) have even been shown to disappear completely, but fibrosis does not completely resolve by 12 months post-MBS. To better understand the outcome of pediatric MASLD following MBS treatment, more longitudinal radiographic data and liver histology in patients with fibrosis would be informative beyond 12 months post-MBS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryPediatric ObesityObesity, MorbidHumansAdolescentTreatment OutcomeFatty LiverFemaleMale

Stichwörter der Autor:innen

Bariatric surgeryLong-term outcomesObesityProcedure type

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, & Nutrition, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Ill…
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. Electronic address: jryder@luriechildrens.org.

Zitieren

APA

Brichta, C., Fishbein, M., & Ryder, J. R. (2025). Outcomes of adolescent bariatric surgery: liver disease. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2024.08.040

Vancouver

Brichta C, Fishbein M, Ryder JR. Outcomes of adolescent bariatric surgery: liver disease. Surgery for Obesity and Related Diseases. 2025. doi:10.1016/j.soard.2024.08.040

BibTeX
@article{Brichta2025,
  author = {Brichta, Christine and Fishbein, Mark and Ryder, Justin R},
  title = {Outcomes of adolescent bariatric surgery: liver disease},
  journal = {Surgery for Obesity and Related Diseases},
  year = {2025},
  doi = {10.1016/j.soard.2024.08.040}
}
Kostenlos starten →